FundingWatcher
Home / Startups / Top biotech startups / Biotech startups in San Francisco, United States

Biotech startups in San Francisco, United States

Updated 16 Nov 2026

Reset
Biotech startups in San Francisco, United States
One-time CSV
  • 396 funded companies, 345 with a website
  • Last round, amount, date, total raised and investors
  • CRM-ready CSV, 18 columns
  • Download right after payment
With founder contacts
Compiled to order
  • The full startup CSV, plus founders and executives
  • Up to 2 founders or CEOs per company, compiled to order
  • Name, job title and LinkedIn URL where found
  • Verified direct email per person
  • Startup CSV at once, contacts CSV by mail within 24 hours
Download right after paymentFree 10-row sampleSecure checkout by Stripe

Not sure about the data?

Download a free 10-row sample first. No account, no payment.

startups-biotech~san-francisco-california.csv396 rows × 18 columns
CompanyCityLast roundAmountDate
Multiply LabsSan FranciscoSeries B$75.0M2026-10-06
Chai DiscoverySan FranciscoSeries C$400.0M2026-07-14
Unlearn.AISan FranciscoSeries C$50.0M2024-02-08
LoyalSan FranciscoSeries C$100.0M2026-02-11
Medra AISan FranciscoSeries A$52.0M2025-12-11
Incode TechnologiesSan FranciscoSeries B$220.0M2021-12-07
MithrlSan FranciscoSeries A$20.0M2026-09-15
Probably GeneticSan FranciscoSeries A$12.0M2026-10-15

8 rows of the CSV in 5 of its 18 columns.

396
Startups
$14.6B
Total raised
87
Funded in the last 12 months
$2.4B
Raised in the last 12 months

Source: FundingWatcher. Data as of 16 November 2026. "Last 12 months" is the 365 days to that date.

Newest rounds

24 of 396
24 rows
Company What they do Sector Last round Amount Date Total raised Investors Employees Founded
Probably Genetic Probably Genetic develops treatments aimed at improving the lives of patients with severe, complex diseases. Artificial intelligence Series A $12.0M 2026-10-15 $22.9M Y Combinator, Khosla Ventures, TenOneTen Ventures +2 11 to 50 2018
Multiply Labs Multiply Labs builds robotic systems that automate biologics manufacturing. Artificial intelligence Series B $75.0M 2026-10-06 $97.7M Y Combinator, Founders Fund, Garage Capital +2 11 to 50 2016
Mithrl Mithrl is a software development company that builds custom NGS data workflows on demand. Artificial intelligence Series A $20.0M 2026-09-15 $24.0M Bonfire Ventures 51 to 100 2023
Chai Discovery Chai Discovery develops artificial intelligence models and software for protein engineering and molecular design. Artificial intelligence Series C $400.0M 2026-07-14 $631.0M Thrive Capital, OpenAI 11 to 50 2024
Kopra Bio Kopra Bio develops viral immunotherapy treatments to cure cancer. Biotech Seed $9.1M 2026-06-16 $9.7M Y Combinator, Pioneer Fund 1 to 10 2024
ParcelBio ParcelBio develops RNA medicine delivery systems and therapeutic development platforms. Biotech Seed $13.0M 2026-05-07 $13.5M Y Combinator, Alumni Ventures, Pioneer Fund +2 1 to 10 2024
LTZ Therapeutics LTZ Therapeutics develops novel immunotherapies for cancer and other diseases with unmet clinical needs. Biotech Series B $38.0M 2026-05-06 $125.0M Qiming Venture Partners, Shunwei Capital, K2VC +1 11 to 50 2022
Fermeate Fermeate provides photomolecular fermentation technology that makes biomanufacturing more sustainable and efficient. Biotech Seed $2.5M 2026-04-27 $2.5M SOSV, SOSV SF & NY (Fka IndieBio) 1 to 10 2024
Terremoto Biosciences Terremoto Biosciences develops medicines using lysine-based covalent chemistry. Biotech Series C $108.0M 2026-04-15 $358.0M OrbiMed, Novo Holdings, Third Rock Ventures +2 51 to 100 2021
TippingPoint Biosciences TippingPoint Biosciences develops therapeutics that target genome packaging states in diseases such as cancer. Biotech Seed $4.5M 2026-03-31 $4.5M SOSV, SOSV SF & NY (Fka IndieBio) 1 to 10 2022
Numerion Labs Numerion Labs develops artificial intelligence systems for drug discovery using deep learning algorithms. Artificial intelligence Series D $19.8M 2026-03-19 $241.4M Y Combinator, Khosla Ventures, Creative Destruction Lab +1 11 to 50 2012
Loyal Loyal develops veterinary medicines to extend the healthy lifespan of senior dogs. Biotech Series C $100.0M 2026-02-11 $237.1M Khosla Ventures, First Round Capital, Quiet Capital +1 101 to 250 2019
Ligo Biosciences Ligo Biosciences develops deep-learning models for enzyme design to lower the cost of chemical manufacturing. Biotech Seed $500K 2026-01-01 $500K Y Combinator 1 to 10 2024
1849 Bio 1849 Bio creates microbes that extract metals affordably from low-grade copper and gold ores. Biotech Seed $500K 2026-01-01 $500K Y Combinator 1 to 10 2024
Culture Biosciences Culture Biosciences provides automated systems for bioprocess development of biological products. Biotech Series C $80.0M 2025-12-16 $101.6M Y Combinator, National Science Foundation, BoxGroup +1 101 to 250 2016
Aeovian Pharmaceuticals Aeovian Pharmaceuticals develops and commercializes therapeutics for rare and age-related diseases. Biotech Series B $55.0M 2025-12-16 $142.0M Sofinnova Investments, venBio Partners, Apollo Health Ventures 1 to 10 2012
Medra AI Medra AI builds an autonomous scientific experimentation platform that combines robotics with artificial intelligence. Artificial intelligence Series A $52.0M 2025-12-11 $63.0M PharmStars 11 to 50 2021
Artos Artos is an AI document-drafting platform that turns life sciences data and reports into submission packages. Artificial intelligence Pre-seed $500K 2024-02-27 $500K Y Combinator, Pioneer Fund 1 to 10 2023
Unlearn.AI Unlearn.AI uses AI, digital twins, and statistical methods to enable smaller, more efficient clinical trials. Artificial intelligence Series C $50.0M 2024-02-08 $134.8M Alumni Ventures, Insight Partners, 8VC +2 51 to 100 2017
Aizon Aizon provides a cloud-based SaaS platform that improves industrial processes in biotech and pharma. Artificial intelligence Series C $20.0M 2024-02-07 $44.8M 500 Global, FundersClub, Uncork Capital +2 101 to 250 2013
Aiolos Bio Aiolos Bio is a biotech company developing therapies for respiratory diseases and immune conditions. Biotech Series A $245.0M 2023-10-24 $245.0M RA Capital Management, Atlas Venture, Forbion Capital Partners +2 11 to 50 2023
Incode Technologies Unicorn Incode Technologies provides omnichannel biometric identity verification for real-life identity checks. Biotech Series B $220.0M 2021-12-07 $257.1M FJ Labs, SoftBank, Framework Ventures +2 501 to 1,000 2015
Qualio Qualio provides a quality management system for life sciences companies. Biotech Series B $50.0M 2021-05-25 $66.1M 500 Global, Tiger Global Management, Menlo Ventures +2 51 to 100 2012
Atexto Atexto provides voice data solutions that enable voice interfaces as alternatives to keyboards. Artificial intelligence Seed $713K 2019-12-02 $1.1M 500 Global, Start-Up Chile, Redwood Capital Partners +2 10,001 or more 2018

Table 1. Biotech startups in San Francisco, United States: the 24 newest rounds whose row carries a description, a city, a named fund and an amount. Source: FundingWatcher. Data as of 16 November 2026. Base: 396.

Largest rounds

Last 12 months
10 rows
# Company What they do Sector Last round Amount Date Total raised Investors Employees Founded
1 Chai Discovery Chai Discovery develops artificial intelligence models and software for protein engineering and molecular design. Artificial intelligence Series C $400.0M 2026-07-14 $631.0M Thrive Capital, OpenAI 11 to 50 2024
2 Terremoto Biosciences Terremoto Biosciences develops medicines using lysine-based covalent chemistry. Biotech Series C $108.0M 2026-04-15 $358.0M OrbiMed, Novo Holdings, Third Rock Ventures +2 51 to 100 2021
3 Loyal Loyal develops veterinary medicines to extend the healthy lifespan of senior dogs. Biotech Series C $100.0M 2026-02-11 $237.1M Khosla Ventures, First Round Capital, Quiet Capital +1 101 to 250 2019
4 Culture Biosciences Culture Biosciences provides automated systems for bioprocess development of biological products. Biotech Series C $80.0M 2025-12-16 $101.6M Y Combinator, National Science Foundation, BoxGroup +1 101 to 250 2016
5 Multiply Labs Multiply Labs builds robotic systems that automate biologics manufacturing. Artificial intelligence Series B $75.0M 2026-10-06 $97.7M Y Combinator, Founders Fund, Garage Capital +2 11 to 50 2016
6 Aeovian Pharmaceuticals Aeovian Pharmaceuticals develops and commercializes therapeutics for rare and age-related diseases. Biotech Series B $55.0M 2025-12-16 $142.0M Sofinnova Investments, venBio Partners, Apollo Health Ventures 1 to 10 2012
7 Medra AI Medra AI builds an autonomous scientific experimentation platform that combines robotics with artificial intelligence. Artificial intelligence Series A $52.0M 2025-12-11 $63.0M PharmStars 11 to 50 2021
8 LTZ Therapeutics LTZ Therapeutics develops novel immunotherapies for cancer and other diseases with unmet clinical needs. Biotech Series B $38.0M 2026-05-06 $125.0M Qiming Venture Partners, Shunwei Capital, K2VC +1 11 to 50 2022
9 Mithrl Mithrl is a software development company that builds custom NGS data workflows on demand. Artificial intelligence Series A $20.0M 2026-09-15 $24.0M Bonfire Ventures 51 to 100 2023
10 Numerion Labs Numerion Labs develops artificial intelligence systems for drug discovery using deep learning algorithms. Artificial intelligence Series D $19.8M 2026-03-19 $241.4M Y Combinator, Khosla Ventures, Creative Destruction Lab +1 11 to 50 2012

Table 2. Biotech startups in San Francisco, United States: the 10 largest rounds of the last 12 months. Source: FundingWatcher. Data as of 16 November 2026.

Most active investors

By companies backed
#InvestorTypeLocation CompaniesShare Funded, 12 monthsLatest
1 Y Combinator Startup accelerator Mountain View, United States 34 9% 9 Probably Genetic, Multiply Labs, Kopra Bio
2 Khosla Ventures Venture capital firm Menlo Park, United States 7 2% 3 Probably Genetic, Numerion Labs, Loyal
3 SOSV Venture capital firm Princeton, United States 7 2% 3 Farm Minerals, Fermeate, TippingPoint Biosciences
4 Alumni Ventures Angel group Manchester, United States 6 2% 1 ParcelBio
5 SOSV SF & NY (Fka IndieBio) Venture capital firm San Francisco, United States 6 2% 3 Farm Minerals, Fermeate, TippingPoint Biosciences
6 Pioneer Fund Startup accelerator Toronto, Canada 6 2% 3 Kopra Bio, ParcelBio, Angstrom AI
7 500 Global Startup accelerator Palo Alto, United States 5 1%
8 Felicis Venture capital firm Menlo Park, United States 4 1%
9 RA Capital Management Startup incubator Boston, United States 4 1%
10 Sofinnova Investments Venture capital firm Menlo Park, United States 3 1% 1 Aeovian Pharmaceuticals
11 Lux Capital Venture capital firm New York, United States 3 1%
12 Bristol-Myers Squibb Venture capital firm New York, United States 3 1%
13 Founders Fund Venture capital firm San Francisco, United States 2 1% 1 Multiply Labs
14 8VC Venture capital firm Austin, United States 2 1%
15 FJ Labs Micro VC fund New York, United States 2 1%

Table 3. Biotech startups in San Francisco, United States: the funds recorded as investors in the most companies. Latest: companies they back that raised in the last 12 months. Source: FundingWatcher. Data as of 16 November 2026.

Sectors

SectorsCompaniesShareTotal raised
Health care 269 68% $11.8B
Software 133 34% $4.1B
Artificial intelligence 99 25% $2.6B
Hardware 18 5% $899.5M
Cybersecurity 7 2% $297.7M
Fintech 5 1% $434.2M
Energy 5 1% $225.1M
Education 2 1%
Commerce 1 0% $74.4M

Table 4. Biotech startups in San Francisco, United States by sector. Source: FundingWatcher. Data as of 16 November 2026.

Funding stage

Funding stageCompaniesShareMedian last round
Pre-seed 80 20% $500K
Seed 172 43% $2.9M
Series A 77 19% $23.0M
Series B 34 9% $40.0M
Series C 26 7% $55.0M
Series D+ 7 2% $43.0M

Table 5. Biotech startups in San Francisco, United States by stage of the most recent round. Source: FundingWatcher. Data as of 16 November 2026.

Rounds by month

Rounds by monthCompaniesShareRaised
October 2026 9 10% $290.9M
September 2026 3 3% $21.0M
August 2026 7 8% $133.0M
July 2026 6 7% $418.1M
June 2026 6 7% $200.6M
May 2026 6 7% $68.2M
April 2026 7 8% $138.8M
March 2026 13 15% $53.1M
February 2026 2 2% $100.5M
January 2026 15 17% $537.2M
December 2025 11 13% $414.6M
November 2025 2 2% $16.0M

Table 6. Biotech startups in San Francisco, United States: most recent round by month, last 12 months. Source: FundingWatcher. Data as of 16 November 2026.

Most recent round by year

Most recent round by yearCompaniesShareRaised
2026 74 19% $2.0B
2025 65 16% $1.5B
2024 48 12% $675.1M
2023 31 8% $581.2M
2022 26 7% $482.1M
2021 31 8% $3.8B

Table 7. Biotech startups in San Francisco, United States by year of the most recent round. Source: FundingWatcher. Data as of 16 November 2026.

Founding year

Founding yearCompaniesShare
2023 or later 128 33%
2020 to 2022 65 17%
2015 to 2019 112 29%
2010 to 2014 54 14%
Before 2010 33 8%

Table 8. Biotech startups in San Francisco, United States by founding year. Source: FundingWatcher. Data as of 16 November 2026.

Team size

Team sizeCompaniesShare
1 to 10 219 56%
11 to 50 125 32%
51 to 100 27 7%
101 to 250 10 3%
251 to 500 2 1%
501 to 1,000 2 1%
1,001 to 5,000 1 0%
10,001 or more 3 1%

Table 9. Biotech startups in San Francisco, United States by headcount. Source: FundingWatcher. Data as of 16 November 2026.

Method

Sources, fields and exclusions of both files: Method.

Questions

How many biotech startups in San Francisco, United States are on the list?
396, in the file dated 16 November 2026. 87 of them closed their most recent round in the last 12 months.
What does the CSV contain?
One row per company, 18 columns: name, domain, website, linkedin, description, founded, employees, city, region, country, sectors, funding_stage, last_round, last_round_date, last_round_usd, total_raised_usd, rounds, investors.
How much does the list cost?
$29 one-time for all 396 rows, no account. Every investor and every startup, two files, cost $99. With founder contacts, up to 2 founders or CEOs per company compiled to order and mailed within 24 hours, $199.
What arrives after payment?
At once: the CSV download link, on the page after payment and by mail.
Can I see rows before buying?
The 3 rows under the buy button are rows of the CSV with every column. The form below it mails 10 rows.
How current is the data?
The file is dated 16 November 2026. The download link serves the current file each time it is opened.

Biotech startups in San Francisco, United States: 396 rows, CSV, $29 one-time.

At once: the CSV download link, on the page after payment and by mail.

Columns: name, domain, website, linkedin, description, founded, employees, city, region, country, sectors, funding_stage, last_round, last_round_date, last_round_usd, total_raised_usd, rounds, investors.

With founder contacts: $199 one-time. List CSV right after payment; up to 2 verified founder or CEO emails per company compiled to order within 24 hours.

Not sure about the data?

Download a free 10-row sample first. No account, no payment.

Biotech startups in San Francisco, United States by funding stage

Other sectors in San Francisco

Biotech startups elsewhere

Cite: FundingWatcher, 396 funded biotech companies in San Francisco, United States, 16 November 2026. https://fundingwatcher.com/startups/biotech/san-francisco-california/